"Vaccines, Subunit" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines consisting of one or more antigens that stimulate a strong immune response. They are purified from microorganisms or produced by recombinant DNA techniques, or they can be chemically synthesized peptides.
| Descriptor ID |
D022223
|
| MeSH Number(s) |
D20.215.894.860
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Vaccines, Subunit".
Below are MeSH descriptors whose meaning is more specific than "Vaccines, Subunit".
This graph shows the total number of publications written about "Vaccines, Subunit" by people in this website by year, and whether "Vaccines, Subunit" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 2 | 2 |
| 2008 | 0 | 2 | 2 |
| 2009 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 3 | 3 |
| 2014 | 1 | 3 | 4 |
| 2015 | 1 | 3 | 4 |
| 2016 | 0 | 4 | 4 |
| 2017 | 5 | 19 | 24 |
| 2018 | 8 | 16 | 24 |
| 2019 | 5 | 12 | 17 |
| 2020 | 5 | 13 | 18 |
| 2021 | 3 | 12 | 15 |
To return to the timeline, click here.
Below are the most recent publications written about "Vaccines, Subunit" by people in Profiles.
-
Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates. Emerg Microbes Infect. 2021 Dec; 10(1):629-637.
-
A novel DNA and protein combination COVID-19 vaccine formulation provides full protection against SARS-CoV-2 in rhesus macaques. Emerg Microbes Infect. 2021 Dec; 10(1):342-355.
-
Large-Scale Identification of T-Cell Epitopes Derived From Severe Acute Respiratory Syndrome Coronavirus 2 for the Development of Peptide Vaccines Against Coronavirus Disease 2019. J Infect Dis. 2021 09 17; 224(6):956-966.
-
Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques. Nat Commun. 2021 09 01; 12(1):5215.
-
In-silico immunoinformatic analysis of SARS-CoV-2 virus for the development of putative vaccine construct. Immunobiology. 2021 09; 226(5):152134.
-
The impact of spike mutated variants of SARS-CoV2 [Alpha, Beta, Gamma, Delta, and Lambda] on the efficacy of subunit recombinant vaccines. Braz J Infect Dis. 2021 Jul-Aug; 25(4):101606.
-
BCG Vaccine Derived Peptides Induce SARS-CoV-2 T Cell Cross-Reactivity. Front Immunol. 2021; 12:692729.
-
Improvement of a SARS-CoV-2 vaccine by enhancing the conjugation efficiency of the immunogen to self-assembled nanoparticles. Cell Mol Immunol. 2021 08; 18(8):2042-2044.
-
Key Considerations for the Development of Safe and Effective SARS-CoV-2 Subunit Vaccine: A Peptide-Based Vaccine Alternative. Adv Sci (Weinh). 2021 08; 8(16):e2100985.
-
The need for broadly protective COVID-19 vaccines: Beyond S-only approaches. Vaccine. 2021 07 13; 39(31):4239-4241.